This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biondi, B. Articles by Perticone, F. Search for Related Content PubMed PubMed Citation Articles by Biondi, B. Articles by Perticone, F.

Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients*

Departments of Endocrinology (B.B., G.L.) and Internal Medicine (E.A.P., S.F., L.S.), University of Naples "Federico II" Medical School, 80131 Naples, Italy; and Department of Clinical and Experimental Medicine (C.C., M.N., S.F., F.P.), University of Catanzaro "Magna Grecia" Medical School, 88100 Catanzaro, Italy

Address correspondence and requests for reprints to: Dott.ssa Bernadette Biondi, Università degli Studi "Federico II" di Napoli, Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, via S. Pansini, 5, 80131 Napoli, Italy. E-mail: bebiondi{at}libero.it * Presented in part at the 72nd Annual

To determine the clinical impact of endogenous subclinical hyperthyroidism, specific symptoms and signs of thyroid hormone excess and quality of life were assessed in 23 patients (3 males and 20 females; mean age, 43 ± 9 yr) and 23 age-, sex-, and lifestyle-matched normal subjects by using the Symptoms Rating Scale and the Short Form 36 Health Survey questionnaires. Because the heart is one of the main target organs of the thyroid hormone, cardiac morphology and function were also investigated by means of standard 12-lead electrocardiogram (ECG), 24-h Holter ECG, and complete Doppler echocardiography. Stable endogenous subclinical hyperthyroidism had been diagnosed in all patients at least 6 months before the study (TSH, 0.15 ± 0.1 mU/L; free T₃, 6.9 ± 1.1, pmol/L; free T₄, 17.2 ± 2.3, pmol/L). Fifteen patients were affected by multinodular goiter, and eight patients by autonomously functioning thyroid nodule. The mean Symptoms Rating Scale score (9.8 ± 5.5 vs. 4.3 ± 2.2, P < 0.001) and both the mental (36.1 ± 9.5 vs. 50.0 ± 8.5, P < 0.001) and physical (42.6 ± 8.0 vs. 55.6 ± 4.1, P < 0.001) component scores of Short Form 36 Health Survey documented a significant prevalence of specific symptoms and signs of thyroid hormone excess and notable impairment of quality of life in patients. Holter ECG showed a higher prevalence of atrial premature beats in endogenous subclinical hyperthyroid patients than in the controls, but the difference was not statistically significant, although the average heart rate was significantly increased in the patients (P < 0.001). An increase of left ventricular mass (162 ± 24 vs. 132 ± 22 g, P < 0.001) due to the increase of septal (P = 0.025) and posterior wall (P = 0.004) thickness was observed in patients. Systolic function was enhanced in patients as shown by the significant increase of both fractional shortening (P = 0.005) and mean velocity of heart rate-adjusted circumferential fiber shortening (P = 0.036). The Doppler parameters of diastolic function were significantly impaired in the patients as documented by the reduced early to late ratio of the transmitral flow velocities (P < 0.001) and the prolonged isovolumic relaxation time (P = 0.006).

These data indicate that endogenous subclinical hyperthyroidism has a relevant clinical impact and that it affects cardiac morphology and function. Moreover, they suggest that treatment of persistent endogenous subclinical hyperthyroidism should be considered also in young and middle-aged patients to attenuate specific symptoms and signs of thyroid hormone excess, ameliorate the quality of life, and avoid the consequences to the heart of long exposure to a mild excess of thyroid hormone.

This article has been cited by other articles:

				M. H. Samuels, K. G. Schuff, N. E. Carlson, P. Carello, and J. S. Janowsky Health Status, Mood, and Cognition in Experimentally Induced Subclinical Thyrotoxicosis J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1730 - 1736. [Abstract] [Full Text] [PDF]

				H. C. Hoftijzer, K. A. Heemstra, E. P. M. Corssmit, A. A. van der Klaauw, J. A. Romijn, and J. W. A. Smit Quality of Life in Cured Patients with Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 200 - 203. [Abstract] [Full Text] [PDF]

				I. Klein and S. Danzi Thyroid Disease and the Heart Circulation, October 9, 2007; 116(15): 1725 - 1735. [Abstract] [Full Text] [PDF]

				A. R. Cappola Subclinical Thyroid Dysfunction and the Heart J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3404 - 3405. [Full Text] [PDF]

				A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde Thyroid Stimulating Hormone and Left Ventricular Function J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3504 - 3510. [Abstract] [Full Text] [PDF]

				H. Volzke, C. Schwahn, H. Wallaschofski, and M. Dorr The Association of Thyroid Dysfunction with All-Cause and Circulatory Mortality: Is There a Causal Relationship? J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2421 - 2429. [Abstract] [Full Text] [PDF]

				M. D. Gammage, J. V. Parle, R. L. Holder, L. M. Roberts, F. D. R. Hobbs, S. Wilson, M. C. Sheppard, and J. A. Franklyn Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation Arch Intern Med, May 14, 2007; 167(9): 928 - 934. [Abstract] [Full Text] [PDF]

				F. Osman, J. A. Franklyn, R. L. Holder, M. C. Sheppard, and M. D. Gammage Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study J. Am. Coll. Cardiol., January 2, 2007; 49(1): 71 - 81. [Abstract] [Full Text] [PDF]

				D. S. Cooper Approach to the Patient with Subclinical Hyperthyroidism J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 3 - 9. [Abstract] [Full Text] [PDF]

				T. Watt, M. Groenvold, A. K. Rasmussen, S. J. Bonnema, L. Hegedus, J. B. Bjorner, and U. Feldt-Rasmussen Quality of life in patients with benign thyroid disorders. A review. Eur. J. Endocrinol., April 1, 2006; 154(4): 501 - 510. [Abstract] [Full Text] [PDF]

				A. R. Cappola, L. P. Fried, A. M. Arnold, M. D. Danese, L. H. Kuller, G. L. Burke, R. P. Tracy, and P. W. Ladenson Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults JAMA, March 1, 2006; 295(9): 1033 - 1041. [Abstract] [Full Text] [PDF]

				J. W. A. Smit, C. F. A. Eustatia-Rutten, E. P. M. Corssmit, A. M. Pereira, M. Frolich, G. B. Bleeker, E. R. Holman, E. E. van der Wall, J. A. Romijn, and J. J. Bax Reversible Diastolic Dysfunction after Long-Term Exogenous Subclinical Hyperthyroidism: A Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6041 - 6047. [Abstract] [Full Text] [PDF]

				K Boelaert and J A Franklyn Thyroid hormone in health and disease J. Endocrinol., October 1, 2005; 187(1): 1 - 15. [Abstract] [Full Text] [PDF]

				G. J. Kahaly and W. H. Dillmann Thyroid Hormone Action in the Heart Endocr. Rev., August 1, 2005; 26(5): 704 - 728. [Abstract] [Full Text] [PDF]

				M. Casu, C. Cappi, V. Patrone, E. Repetto, M. Giusti, F. Minuto, and G. Murialdo Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer Eur. J. Endocrinol., June 1, 2005; 152(6): 819 - 824. [Abstract] [Full Text] [PDF]

				C. C. Albino, C. O. Mesa Jr., M. Olandoski, C. E. Ueda, L. C. Woellner, C. A. Goedert, A. M. Souza, and H. Graf Recombinant Human Thyrotropin as Adjuvant in the Treatment of Multinodular Goiters with Radioiodine J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2775 - 2780. [Abstract] [Full Text] [PDF]

				M. Dorr, B. Wolff, D. M. Robinson, U. John, J. Ludemann, W. Meng, S. B. Felix, and H. Volzke The Association of Thyroid Function with Cardiac Mass and Left Ventricular Hypertrophy J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 673 - 677. [Abstract] [Full Text] [PDF]

				B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi Subclinical hyperthyroidism: clinical features and treatment options Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9. [Abstract] [Full Text] [PDF]

				N. Tribulova, V. Knezl, L. Okruhlicova, J. Drimal, D. Lamosova, J. Slezak, and J. Styk L-thyroxine increases susceptibility of adult rats to low K+-induced ventricular fibrillation, and sinus rhythm restoration in old rats Exp Physiol, September 1, 2004; 89(5): 629 - 636. [Abstract] [Full Text] [PDF]

				E H Hoogendoorn, M den Heijer, A P J van Dijk, and A R Hermus Subclinical hyperthyroidism: to treat or not to treat? Postgrad. Med. J., July 1, 2004; 80(945): 394 - 398. [Abstract] [Full Text] [PDF]

				M. Helfand Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, January 20, 2004; 140(2): 128 - 141. [Abstract] [Full Text] [PDF]

				M. I. Surks, E. Ortiz, G. H. Daniels, C. T. Sawin, N. F. Col, R. H. Cobin, J. A. Franklyn, J. M. Hershman, K. D. Burman, M. A. Denke, et al. Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management JAMA, January 14, 2004; 291(2): 228 - 238. [Abstract] [Full Text] [PDF]

				J. A. Sgarbi, F. G. Villaca, B. Garbeline, H. E. Villar, and J. H. Romaldini The Effects of Early Antithyroid Therapy for Endogenous Subclinical Hyperthyroidism in Clinical and Heart Abnormalities J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1672 - 1677. [Abstract] [Full Text] [PDF]

				B. Biondi, E. A. Palmieri, G. Lombardi, and S. Fazio Effects of Subclinical Thyroid Dysfunction on the Heart Ann Intern Med, December 3, 2002; 137(11): 904 - 914. [Abstract] [Full Text] [PDF]

				L. Tauchmanova, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.-A. Palmieri, S. Fazio, and G. Lombardi Patients with Subclinical Cushing's Syndrome due to Adrenal Adenoma Have Increased Cardiovascular Risk J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4872 - 4878. [Abstract] [Full Text] [PDF]

				A. Stagnaro-Green Postpartum Thyroiditis J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4042 - 4047. [Full Text] [PDF]

				D. Edelman, M. K. Olsen, T. K. Dudley, A. C. Harris, and E. Z. Oddone Impact of Diabetes Screening on Quality of Life Diabetes Care, June 1, 2002; 25(6): 1022 - 1026. [Abstract] [Full Text] [PDF]

				C. Meier, J.-J. Staub, C.-B. Roth, M. Guglielmetti, M. Kunz, A. R. Miserez, J. Drewe, P. Huber, R. Herzog, and B. Muller TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study) J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4860 - 4866. [Abstract] [Full Text] [PDF]

				A. D. Toft Subclinical Hyperthyroidism N. Engl. J. Med., August 16, 2001; 345(7): 512 - 516. [Full Text] [PDF]